New data suggest that patients taking disease-modifying antirheumatic drugs (DMARDs) should continue to get vaccinated against SARS-CoV-2.
Many patients with autoimmune disease suffer from conditions that cause inflammation and thus place them at higher risk for serious cases of COVID-19. These patients often take DMARDs to treat their underlying condition, but unfortunately, patients treated with DMARDs have a less robust response to COVID-19 vaccination than people who don’t use these